Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Contacts
location
Contact Email
Website URL
Similar Companies1000
Quan Capital
Quan Capital is a healthcare-focused venture capital firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Tall Oaks Capital Partners
Tall Oaks Capital Partners is a venture capital firm specializing in seed and early stage investments in fast-growing technology companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Innogest Capital
Innogest Capital is a venture capital firm that invests in seed and early stage ventures in the healthcare and digital sectors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Numoda Capital Innovations
Numoda Capital Innovations is a corporate venture capital firm based in Pennsylvania that focuses on life science and novel technologies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Financials
Investments11
Trio Labs
Trio Labs specializes in high volume additive manufacturing of precision metal and ceramic components for healthcare.
Sector
Subsector
Location
total rounds
total raised
ProbiusDx
Probius is an electronic sensing company that provides a diagnostic technology for detecting and monitoring blood concentrations.
Sector
Subsector
Location
total rounds
total raised
Chromatan
ChromaTan develops continuous countercurrent tangential chromatography for monoclonal antibody and protein purification.
Sector
Subsector
Keywords
Location
total rounds
Co-Investors
People
Founders3
Eric Tan
There is an abundance of untapped technology that can, individually, make life so much better for billions of people around the world. Yet, most of this technology stays untapped because of the lack of funding or lack of understanding from investors. Through Zoic Capital, I look to bridge that gap. My work consists of finding the right companies to invest in and then linking them with investment opportunities and ensuring they grow in the right way to maximize the benefit to humanity. At Zoic, I lead the effort to find and do due diligence on the companies we invest in, helping them grow in their technology and IP portfolios after we invest. Zoic Capital is currently the only US-based venture firm focused solely on investing in the seed stage of med-tech, going through a rigorous vetting process with each investment opportunity to ensure that: 1. their technological developments represent at least a 10X improvement in the current standard of care 2. their technology relies on scientific mechanisms which are fully supported by published literature, independent trials, and personal observation 3. in most cases, they have unique hardware and IP coupled with unique software 4. the leadership team has the necessary combination of vision and experience to create a transformational company 5. they have initial regulatory approval on a short timeline, typically two to four years. If you want to learn more about Zoic, the types of companies we invest in, or if you’d like to talk about cars, send me an email: [email protected] If you know of an interesting deal for Zoic to look at, feel free to get in touch with my team here: [email protected]
current job
Eric Tan
Neal Mody
I’m obsessed with building great companies and focus on those life sciences that will affect humanity. Early in my career, I was fortunate enough to help scale Ambature, a materials science company in the field of superconductivity. When I started Ambature, I didn’t have any experience in materials science; nevertheless, I operated under the belief that the inventor’s idea was right. Fast forward a few years, by the time I left my role, we created over 200 patents with more than 3,700 unique claims, accounting for more than half patents in the field of superconductivity. After I left Ambature, I wanted to make a more significant impact in life sciences, and ultimately on humanity. Being driven by this social mission, I thought about starting a few companies simultaneously; however, after some back and forth, I ultimately concluded that starting a fund would better allow me to scale my efforts. Through Zoic Capital, my team and I help our portfolio companies and investors: ► Develop large scale inclusive IP development strategy ► Help connect and codevelop deals with potential strategic acquirers We are currently the only US-based venture firm focused solely on investing in the seed stage of Medtech, we go through a rigorous vetting process with each investment opportunity to ensure that: 1. their technological developments represent at least a 10X improvement in the standard of care 2. their technology relies upon scientific mechanisms which are fully supported by published literature, independent trials, and personal observation 3. in most cases, they have unique hardware and IP coupled with unique software 4. the leadership team has the necessary combination of vision and experience to create a transformational company 5. has an initial regulatory approval on a short timeline, typically two to four years If you want to learn more about Zoic, the types of companies we invest in, or if you’d like to talk about the market and feature on my podcast, feel free to get in touch with me via email: [email protected] If you know of an interesting deal for Zoic to look at, feel free to get in touch with my team here: [email protected]
current job
Neal Mody
Ian Eliason
Naturally, entrepreneurial Ian has been with Zoic since its inception in 2014, when it was little more than a concept on the back of a napkin. He helped develop the investment strategy, build the deal flow network, and constructed the operational infrastructure necessary to launch then manage institutional level capital. Within his role at Zoic Ian has evaluated over 1,000 life sciences companies, and he plays a key role in the firm’s investment decisions including deal selection and structuring. If you want to learn more about Zoic, the types of companies we invest in, or if you’d like to exchange good reads and travel ideas, send me an email: [email protected]
current job
Ian Eliason
